With the pull-forward effect ahead of tariff implementation over, the US vehicle market is expected to slow further in H2.

Investors should have a “keep calm and carry on” approach to financial markets, maintaining a long position in emerging ...

Lunit is collaborating with Microsoft to help bring its AI-powered diagnostics for cancer detection into clinical practice.

Novartis’ Cosentyx (secukinumab) has failed to show any benefit in the Phase III study in adults with newly diagnosed or ...

Organon is terminating development of its endometriosis drug after the Phase II trial failed to show any benefit. The ELENA proof-of-concept study (NCT05560646) was evaluating Organon’s therapy, ...

(Reuters) -U.S. total new vehicle sales are expected to rise 2.5% to 1.25 million units on an adjusted basis for the month of ...

GlobalData, using its Ai Palette platform, presents the ingredients it believes offer opportunities for confectioners to win over snack lovers.

With its blockbuster Trikafta set to lose patent protection within the decade, Vertex is strengthening its cystic fibrosis portfolio.

Some of the retailers that have failed weren’t really innovating or thinking about the customer very well,” one industry ...

The chronic kidney disease (CKD) anemia market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and Japan) is poised to grow at a compound annual growth rate (CAGR) ...

In recent years, cereal milk has been popularized as its own flavor and ingredient, thanks to James Beard Award-winning pastry chef Christina Tosi. In November 2008, Tosi opened the very first Milk ...

India's mobile services revenue is set to rise at a CAGR of 5.4% to reach $39.3 billion by 2029, driven by enhanced mobile ...